AMPH logo

Amphastar Pharmaceuticals (AMPH) Total Expenses

Annual Total Expenses

$447.41 M
+$55.92 M+14.28%

31 December 2023

AMPH Total Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Expenses

$134.17 M
+$6.99 M+5.50%

30 September 2024

AMPH Quarterly Total Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

AMPH Total Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+14.3%+24.4%
3 y3 years+32.0%+53.5%
5 y5 years+47.5%+72.6%

AMPH Total Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+32.0%at high+53.5%
5 y5 yearsat high+47.5%at high+73.8%
alltimeall timeat high+194.7%at high+181.4%

Amphastar Pharmaceuticals Total Expenses History

DateAnnualQuarterly
Sept 2024
-
$134.17 M(+5.5%)
June 2024
-
$127.18 M(+2.7%)
Mar 2024
-
$123.83 M(-0.2%)
Dec 2023
$447.41 M(+14.3%)
$124.13 M(+15.1%)
Sept 2023
-
$107.88 M(-0.9%)
June 2023
-
$108.82 M(+2.1%)
Mar 2023
-
$106.59 M(+9.7%)
Dec 2022
$391.49 M(+6.4%)
$97.19 M(+0.3%)
Sept 2022
-
$96.90 M(-1.8%)
June 2022
-
$98.64 M(-0.1%)
Mar 2022
-
$98.75 M(+2.2%)
Dec 2021
$367.88 M(+8.6%)
$96.64 M(+10.5%)
Sept 2021
-
$87.43 M(-4.0%)
June 2021
-
$91.10 M(-1.7%)
Mar 2021
-
$92.71 M(-0.4%)
Dec 2020
$338.89 M(+5.1%)
$93.04 M(+16.4%)
Sept 2020
-
$79.91 M(-9.9%)
June 2020
-
$88.73 M(+14.9%)
Mar 2020
-
$77.21 M(-7.7%)
Dec 2019
$322.40 M(+6.3%)
$83.63 M(+7.6%)
Sept 2019
-
$77.73 M(-0.4%)
June 2019
-
$78.07 M(-5.9%)
Mar 2019
-
$82.96 M(-5.9%)
Dec 2018
$303.29 M
$88.14 M(+20.8%)
DateAnnualQuarterly
Sept 2018
-
$72.99 M(-1.3%)
June 2018
-
$73.98 M(+8.5%)
Mar 2018
-
$68.17 M(+9.7%)
Dec 2017
$244.09 M(+1.8%)
$62.15 M(+2.1%)
Sept 2017
-
$60.86 M(-3.4%)
June 2017
-
$63.00 M(+8.8%)
Mar 2017
-
$57.91 M(-15.3%)
Dec 2016
$239.79 M(-7.2%)
$68.37 M(+17.0%)
Sept 2016
-
$58.43 M(+1.3%)
June 2016
-
$57.70 M(+4.4%)
Mar 2016
-
$55.29 M(-11.7%)
Dec 2015
$258.42 M(+13.1%)
$62.62 M(-7.4%)
Sept 2015
-
$67.61 M(+5.6%)
June 2015
-
$64.04 M(-0.2%)
Mar 2015
-
$64.15 M(+1.4%)
Dec 2014
$228.44 M(+7.7%)
$63.26 M(-6.3%)
Sept 2014
-
$67.52 M(+35.1%)
June 2014
-
$49.99 M(+4.9%)
Mar 2014
-
$47.67 M(-8.0%)
Dec 2013
$212.06 M(+19.9%)
$51.83 M(-12.3%)
Sept 2013
-
$59.09 M(+16.9%)
June 2013
-
$50.54 M(-0.1%)
Mar 2013
-
$50.61 M
Dec 2012
$176.83 M(+16.5%)
-
Dec 2011
$151.83 M
-

FAQ

  • What is Amphastar Pharmaceuticals annual total expenses?
  • What is the all time high annual total expenses for Amphastar Pharmaceuticals?
  • What is Amphastar Pharmaceuticals annual total expenses year-on-year change?
  • What is Amphastar Pharmaceuticals quarterly total expenses?
  • What is the all time high quarterly total expenses for Amphastar Pharmaceuticals?
  • What is Amphastar Pharmaceuticals quarterly total expenses year-on-year change?

What is Amphastar Pharmaceuticals annual total expenses?

The current annual total expenses of AMPH is $447.41 M

What is the all time high annual total expenses for Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals all-time high annual total expenses is $447.41 M

What is Amphastar Pharmaceuticals annual total expenses year-on-year change?

Over the past year, AMPH annual total expenses has changed by +$55.92 M (+14.28%)

What is Amphastar Pharmaceuticals quarterly total expenses?

The current quarterly total expenses of AMPH is $134.17 M

What is the all time high quarterly total expenses for Amphastar Pharmaceuticals?

Amphastar Pharmaceuticals all-time high quarterly total expenses is $134.17 M

What is Amphastar Pharmaceuticals quarterly total expenses year-on-year change?

Over the past year, AMPH quarterly total expenses has changed by +$26.29 M (+24.37%)